Logo image of TALK

TALKSPACE INC (TALK) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:TALK - US87427V1035 - Common Stock

3.08 USD
-0.09 (-2.84%)
Last: 12/5/2025, 8:00:00 PM
3.0811 USD
+0 (+0.04%)
After Hours: 12/5/2025, 8:00:00 PM
Fundamental Rating

5

TALK gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 100 industry peers in the Health Care Providers & Services industry. While TALK has a great health rating, there are worries on its profitability. TALK is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year TALK was profitable.
TALK had a positive operating cash flow in the past year.
TALK had negative earnings in 4 of the past 5 years.
TALK had negative operating cash flow in 4 of the past 5 years.
TALK Yearly Net Income VS EBIT VS OCF VS FCFTALK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

The Return On Assets of TALK (3.29%) is better than 65.35% of its industry peers.
TALK has a Return On Equity (3.89%) which is in line with its industry peers.
Industry RankSector Rank
ROA 3.29%
ROE 3.89%
ROIC N/A
ROA(3y)-21.22%
ROA(5y)-31.96%
ROE(3y)-25.9%
ROE(5y)-58.19%
ROIC(3y)N/A
ROIC(5y)N/A
TALK Yearly ROA, ROE, ROICTALK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

TALK has a better Profit Margin (1.98%) than 60.40% of its industry peers.
TALK has a Gross Margin of 43.27%. This is in the better half of the industry: TALK outperforms 71.29% of its industry peers.
In the last couple of years the Gross Margin of TALK has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 1.98%
GM 43.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.99%
GM growth 5Y-2.76%
TALK Yearly Profit, Operating, Gross MarginsTALK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50

8

2. Health

2.1 Basic Checks

TALK does not have a ROIC to compare to the WACC, probably because it is not profitable.
TALK has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, TALK has more shares outstanding
There is no outstanding debt for TALK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
TALK Yearly Shares OutstandingTALK Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
TALK Yearly Total Debt VS Total AssetsTALK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 15.00 indicates that TALK is not in any danger for bankruptcy at the moment.
The Altman-Z score of TALK (15.00) is better than 98.02% of its industry peers.
TALK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 15
ROIC/WACCN/A
WACC8.78%
TALK Yearly LT Debt VS Equity VS FCFTALK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

TALK has a Current Ratio of 5.91. This indicates that TALK is financially healthy and has no problem in meeting its short term obligations.
TALK's Current ratio of 5.91 is amongst the best of the industry. TALK outperforms 95.05% of its industry peers.
A Quick Ratio of 5.91 indicates that TALK has no problem at all paying its short term obligations.
TALK has a Quick ratio of 5.91. This is amongst the best in the industry. TALK outperforms 95.05% of its industry peers.
Industry RankSector Rank
Current Ratio 5.91
Quick Ratio 5.91
TALK Yearly Current Assets VS Current LiabilitesTALK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 400.00% over the past year.
Looking at the last year, TALK shows a quite strong growth in Revenue. The Revenue has grown by 18.37% in the last year.
Measured over the past years, TALK shows a very strong growth in Revenue. The Revenue has been growing by 37.48% on average per year.
EPS 1Y (TTM)400%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)18.37%
Revenue growth 3Y18.16%
Revenue growth 5Y37.48%
Sales Q2Q%25.28%

3.2 Future

TALK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 163.81% yearly.
TALK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.05% yearly.
EPS Next Y274.03%
EPS Next 2Y239.99%
EPS Next 3Y163.81%
EPS Next 5YN/A
Revenue Next Year20.73%
Revenue Next 2Y21.47%
Revenue Next 3Y20.42%
Revenue Next 5Y21.05%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
TALK Yearly Revenue VS EstimatesTALK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
TALK Yearly EPS VS EstimatesTALK Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -0.2 -0.4 -0.6

3

4. Valuation

4.1 Price/Earnings Ratio

TALK is valuated quite expensively with a Price/Earnings ratio of 102.67.
Compared to the rest of the industry, the Price/Earnings ratio of TALK is on the same level as its industry peers.
TALK's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.49.
With a Price/Forward Earnings ratio of 26.64, TALK can be considered very expensive at the moment.
TALK's Price/Forward Earnings is on the same level as the industry average.
TALK's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.69.
Industry RankSector Rank
PE 102.67
Fwd PE 26.64
TALK Price Earnings VS Forward Price EarningsTALK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TALK indicates a slightly more expensive valuation: TALK is more expensive than 66.34% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 170.24
TALK Per share dataTALK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

TALK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
TALK's earnings are expected to grow with 163.81% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.37
PEG (5Y)N/A
EPS Next 2Y239.99%
EPS Next 3Y163.81%

0

5. Dividend

5.1 Amount

No dividends for TALK!.
Industry RankSector Rank
Dividend Yield N/A

TALKSPACE INC

NASDAQ:TALK (12/5/2025, 8:00:00 PM)

After market: 3.0811 +0 (+0.04%)

3.08

-0.09 (-2.84%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-30 2025-10-30/bmo
Earnings (Next)02-18 2026-02-18/amc
Inst Owners61.57%
Inst Owner Change0.34%
Ins Owners3.98%
Ins Owner Change1.29%
Market Cap510.23M
Revenue(TTM)214.59M
Net Income(TTM)4.24M
Analysts83.08
Price Target5.18 (68.18%)
Short Float %4.33%
Short Ratio4.74
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-46.51%
Min EPS beat(2)-100%
Max EPS beat(2)6.97%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.48%
Min Revenue beat(2)-0.33%
Max Revenue beat(2)1.3%
Revenue beat(4)1
Avg Revenue beat(4)-1.23%
Min Revenue beat(4)-4.06%
Max Revenue beat(4)1.3%
Revenue beat(8)3
Avg Revenue beat(8)-0.04%
Revenue beat(12)7
Avg Revenue beat(12)1.38%
Revenue beat(16)8
Avg Revenue beat(16)0.5%
PT rev (1m)5.9%
PT rev (3m)5.9%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.71%
EPS NY rev (1m)0%
EPS NY rev (3m)-8.32%
Revenue NQ rev (1m)0.19%
Revenue NQ rev (3m)1.56%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)1.23%
Valuation
Industry RankSector Rank
PE 102.67
Fwd PE 26.64
P/S 2.38
P/FCF N/A
P/OCF 70.48
P/B 4.68
P/tB 4.68
EV/EBITDA 170.24
EPS(TTM)0.03
EY0.97%
EPS(NY)0.12
Fwd EY3.75%
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.04
OCFY1.42%
SpS1.3
BVpS0.66
TBVpS0.66
PEG (NY)0.37
PEG (5Y)N/A
Graham Number0.67
Profitability
Industry RankSector Rank
ROA 3.29%
ROE 3.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 1.98%
GM 43.27%
FCFM N/A
ROA(3y)-21.22%
ROA(5y)-31.96%
ROE(3y)-25.9%
ROE(5y)-58.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.99%
GM growth 5Y-2.76%
F-Score7
Asset Turnover1.66
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 395.89%
Cap/Sales 4.17%
Interest Coverage N/A
Cash Conversion 336.23%
Profit Quality N/A
Current Ratio 5.91
Quick Ratio 5.91
Altman-Z 15
F-Score7
WACC8.78%
ROIC/WACCN/A
Cap/Depr(3y)224%
Cap/Depr(5y)197.42%
Cap/Sales(3y)1.1%
Cap/Sales(5y)1.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)400%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y274.03%
EPS Next 2Y239.99%
EPS Next 3Y163.81%
EPS Next 5YN/A
Revenue 1Y (TTM)18.37%
Revenue growth 3Y18.16%
Revenue growth 5Y37.48%
Sales Q2Q%25.28%
Revenue Next Year20.73%
Revenue Next 2Y21.47%
Revenue Next 3Y20.42%
Revenue Next 5Y21.05%
EBIT growth 1Y98.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year431.28%
EBIT Next 3Y135.51%
EBIT Next 5Y109.41%
FCF growth 1Y94.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y124.89%
OCF growth 3YN/A
OCF growth 5YN/A

TALKSPACE INC / TALK FAQ

What is the fundamental rating for TALK stock?

ChartMill assigns a fundamental rating of 5 / 10 to TALK.


What is the valuation status for TALK stock?

ChartMill assigns a valuation rating of 3 / 10 to TALKSPACE INC (TALK). This can be considered as Overvalued.


What is the profitability of TALK stock?

TALKSPACE INC (TALK) has a profitability rating of 2 / 10.


How financially healthy is TALKSPACE INC?

The financial health rating of TALKSPACE INC (TALK) is 8 / 10.


Can you provide the expected EPS growth for TALK stock?

The Earnings per Share (EPS) of TALKSPACE INC (TALK) is expected to grow by 274.03% in the next year.